NCT07489742 Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Tonsillectomy
| NCT ID | NCT07489742 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tanta University |
| Condition | Ondansetron |
| Study Type | INTERVENTIONAL |
| Enrollment | 210 participants |
| Start Date | 2026-03-25 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 210 participants in total. It began in 2026-03-25 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare the effect of ondansetron lozenge and intravenous for prevention of shivering in tonsillectomy.
Eligibility Criteria
Inclusion Criteria: * Age from 4 to 15 years. * Both sexes. * American Society of Anesthesiology (ASA) physical status I-II. * Children undergoing tonsillectomy under general anesthesia. Exclusion Criteria: * Allergy to ondansetron. * History of sleep apnea. * Cardiac and respiratory diseases. * Upper respiratory tract infection. * Taking corticosteroids.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07489742 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 15 Years, studying Ondansetron. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07489742 currently recruiting?
Yes, NCT07489742 is actively recruiting participants. Contact the research team at mselsharkawy@med.tanta.edu.eg for enrollment information.
Where is the NCT07489742 trial being conducted?
This trial is being conducted at Tanta, Egypt.
Who is sponsoring the NCT07489742 clinical trial?
NCT07489742 is sponsored by Tanta University. The trial plans to enroll 210 participants.